Dengue Fever Treatment Market is expected to grow with a 20% CAGR during 2023 to 2033

The global Dengue Fever Treatment Market is predicted to generate a market value of US$ 877.82 Million in 2023 and a market value of US$ 5435.25 Million by 2023, with a CAGR of 20% from 2023 to 2033. From 2018 to 2022, the market for Dengue Fever Therapy grew at an 11% CAGR. According to …

Vascular Closure Devices Market are set to witness a growth rate of 5.4% CAGR reaching a total valuation of around US$ 2.4 Billion by 2032

The global Vascular Closure Device Market is expected to grow with an opulent CAGR of 5.4% during the forecast period from 2022 to 2032. The global market reached US$ 1.3 Bn in 2021 and is expected to enjoy a valuation of US$ 1.4 Bn by the end of 2022. The surge in usage of vascular closure devices …

Hand Eczema (HE) Treatment Market value of US$ 53 Million in 2023

The global Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023 and is expected to accumulate a market value of US$ 114.42 Million by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Hand Eczema (HE) Treatment registered a CAGR of 4% in the historical period 2018 to 2022. According …

Diabetic Macular Edema Market are set to witness a CAGR of 1.2% and be valued at around US$ 4.2 Billon by 2032

The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Bn by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Bn by the end of 2032. An Uptake of Intravitreal Implants by Patients to Drive Growth of the …

Intratumoral Cancer Therapies Market value of US$ 212.96 Billion in 2023 | FMI

A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be attributed to favorable regulatory frameworks for …

IgA Nephropathy Market value of US$ 85 Billion by registering a CAGR of 7.5% from 2023 to 2033

The market for IgA nephropathy is anticipated to reach US$ 41.24 billion in 2023 and US$ 85 billion by 2033, with a CAGR of 7.5%. The market for IgA nephropathy is expanding as kidney diseases are becoming more common among people of all ages. With respect to the historical period from 2017 to 2022, the …

MRI-Safe Neurostimulation Systems Market is projected to increase at a CAGR of 15.5%  from 2022 to 2032.

[Report of 333 Pages] By 2032, the market for MRI-safe neurostimulation systems is anticipated to be worth US$1,210.0 Million. The market for MRI-safe neurostimulation devices is expanding quickly. MRI-Safe implantable neurostimulation systems are minimally invasive and have registered highest success rates and acceptance over medical treatments. MRI-safe neurostimulation devices find application in chronic pain, epilepsy, …

Focused Ultrasound System Market totalling around US$ 9.2 Billion by 2032

[Report of 250 Pages] In 2022, the market for focused ultrasound systems was estimated to be worth $7 billion. Additionally, the total demand for focused ultrasound systems is anticipated to grow at a strong CAGR of 6.1% between 2022 and 2032, reaching a total of approximately US$ 9.2 Bn by 2032, due to the rising …

Special Purpose Needles Market is expected to reach US$ 27.0 Billion by 2032 exhibit growth at a CAGR of 7.9%

By the end of 2022, the Special Purpose Needles Market is anticipated to be worth US$ 12.6 billion, and it is projected to grow at a CAGR of 7.9% from 2022 to 2032. By the end of 2032, the market is anticipated to be valued at around $27.0 billion USD. The market’s largest region, North …

Mobile Tomography Market is predicted to advance at a CAGR of 5.8% from 2022 to 2032

The global mobile tomography market is anticipated to grow at a 5.8% compound annual growth rate (CAGR) between 2022 and 2032, with revenues of US$ 295.2 million in 2022 and US$ 595.1 million in 2032. Tomography has become a vital tool in the diagnosis of many clinical conditions. Mobile tomography systems are portable and serve imaging …